Status:
COMPLETED
Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of Age
Lead Sponsor:
Instituto Nacional de Salud Publica, Mexico
Collaborating Sponsors:
UNICEF
Conditions:
Diarrhoea;Acute
Diarrhea, Infantile
Eligibility:
All Genders
6-59 years
Phase:
NA
Brief Summary
This study evaluates the effect of zinc over the duration, severity and relapse of acute diarrheic disease, in children between 6 and 59 months of age. One study group will receive a tablet that conta...
Detailed Description
In Mexico acute diarrheal diseases mortality in children continues to be a public health issue, being between the main causes of morbidity and mortality, with an important load for the health systems....
Eligibility Criteria
Inclusion
- Both sexes
- Children attended in the sentinel centers
- Clinical diagnosis of acute diarrhea disease
- Parents have not planned moving to other location in a time period of at least one year.
Exclusion
- Deficient intestinal absorption syndrome
- Acrodermatitis enterohepatic
- Zinc sulfate hypersensitivity
- Leucine metabolic disorders
- Secondary lactose intolerance
- Galactosemia lactase primary deficiency
- Allergy to cow milk protein
- Children that are supplemented with zinc for the last 6 months
Key Trial Info
Start Date :
November 9 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2019
Estimated Enrollment :
529 Patients enrolled
Trial Details
Trial ID
NCT04061538
Start Date
November 9 2017
End Date
January 31 2019
Last Update
August 20 2019
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Pediatrico de Coyoacan
Mexico City, Mexico, 04000
2
Instituto Nacional de Pediatria
Mexico City, Mexico, 04530
3
Hospital Pediatrico La Villa
Mexico City, Mexico, 07050
4
Hospital Pediatrico de Iztapalapa
Mexico City, Mexico, 09070